Amgen Inc/ US0311621009 /
25.06.2024 22:00:00 | Изменение +1.1600 | Объем сделки | Бид22:41:20 | Предложение22:41:20 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
319.3100USD | +0.36% | 3.21 млн Оборот: 688.7 млн |
315.0000Величина цены спроса: 200 | 319.0000Величина цены предложения: 200 | 171.29 млрдUSD | 2.71% | 25.42 |
GlobeNewswire
23:00
authID Announces Pricing of Approximately $11,000,000 Million Registered Direct Offering
GlobeNewswire
23:00
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
22:45
Following Landmark $2.35 Million Georgia Jury Verdict Against “Dangerously Defective Gun” Maker, Law...
GlobeNewswire
22:36
TM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Toyota Motor Corp Ltd Ord Invest...
GlobeNewswire
22:30
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
GlobeNewswire
22:30
argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire
22:20
Neptune Maritime Leasing Awarded Marine Money’s Private Equity Deal of the Year 2023
GlobeNewswire
22:15
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница